SE8801426D0 - Forfarande och medel for blodbehandling - Google Patents

Forfarande och medel for blodbehandling

Info

Publication number
SE8801426D0
SE8801426D0 SE8801426A SE8801426A SE8801426D0 SE 8801426 D0 SE8801426 D0 SE 8801426D0 SE 8801426 A SE8801426 A SE 8801426A SE 8801426 A SE8801426 A SE 8801426A SE 8801426 D0 SE8801426 D0 SE 8801426D0
Authority
SE
Sweden
Prior art keywords
blood
mitogen
blood sample
vitro
bodies
Prior art date
Application number
SE8801426A
Other languages
English (en)
Swedish (sv)
Inventor
Ulf Rothman
Original Assignee
Ulf Rothman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulf Rothman filed Critical Ulf Rothman
Priority to SE8801426A priority Critical patent/SE8801426D0/xx
Publication of SE8801426D0 publication Critical patent/SE8801426D0/xx
Priority to KR1019890702371A priority patent/KR900700131A/ko
Priority to EP19890904646 priority patent/EP0406317A1/en
Priority to JP1504245A priority patent/JPH03503640A/ja
Priority to AU34206/89A priority patent/AU632999B2/en
Priority to PCT/SE1989/000208 priority patent/WO1989009619A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
    • B29C45/17—Component parts, details or accessories; Auxiliary operations
    • B29C45/64—Mould opening, closing or clamping devices
    • B29C45/66—Mould opening, closing or clamping devices mechanical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
    • B29C45/17—Component parts, details or accessories; Auxiliary operations
    • B29C45/64—Mould opening, closing or clamping devices
    • B29C45/66—Mould opening, closing or clamping devices mechanical
    • B29C2045/667—Cam drive for mould closing or clamping

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Manufacturing & Machinery (AREA)
  • Mechanical Engineering (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8801426A 1988-04-15 1988-04-15 Forfarande och medel for blodbehandling SE8801426D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8801426A SE8801426D0 (sv) 1988-04-15 1988-04-15 Forfarande och medel for blodbehandling
KR1019890702371A KR900700131A (ko) 1988-04-15 1989-04-14 유사분열물질에 의한 면역자극 혈액처리를 위한 방법 및 장치
EP19890904646 EP0406317A1 (en) 1988-04-15 1989-04-14 Method and means for immuno-stimulating blood treatment with mitogen
JP1504245A JPH03503640A (ja) 1988-04-15 1989-04-14 血液処理の方法および手段
AU34206/89A AU632999B2 (en) 1988-04-15 1989-04-14 Method and means for immuno-stimulating blood treatment with a mitogen
PCT/SE1989/000208 WO1989009619A1 (en) 1988-04-15 1989-04-14 Method and means for immuno-stimulating blood treatment with mitogen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8801426A SE8801426D0 (sv) 1988-04-15 1988-04-15 Forfarande och medel for blodbehandling

Publications (1)

Publication Number Publication Date
SE8801426D0 true SE8801426D0 (sv) 1988-04-15

Family

ID=20372041

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8801426A SE8801426D0 (sv) 1988-04-15 1988-04-15 Forfarande och medel for blodbehandling

Country Status (6)

Country Link
EP (1) EP0406317A1 (ja)
JP (1) JPH03503640A (ja)
KR (1) KR900700131A (ja)
AU (1) AU632999B2 (ja)
SE (1) SE8801426D0 (ja)
WO (1) WO1989009619A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042837A (en) * 1989-09-20 2000-03-28 Kalland; Terje Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC)
SE8903100D0 (sv) * 1989-09-20 1989-09-20 Pharmacia Ab New pharmaceutical agent
US5728388A (en) * 1989-10-03 1998-03-17 Terman; David S. Method of cancer treatment
CA2078003C (en) * 1990-01-17 2006-11-21 David S. Terman Tumor killing effects of enterotoxins and related compounds
CA2157379A1 (en) * 1993-03-02 1994-09-15 David S. Terman Method of cancer treatment
PT789588E (pt) * 1994-11-17 2005-05-31 Univ South Florida Processo para a producao de um medicamento para o tratamento de imunodeficiencia secundaria
US6977072B2 (en) 2000-10-27 2005-12-20 Irx Therapeutics, Inc. Vaccine immunotherapy for immune suppressed patients
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
DK2234642T3 (en) 2007-11-28 2018-01-08 Irx Therapeutics Inc PROCEDURE FOR INCREASING AN IMMUNOLOGICAL EFFECT
JP5797190B2 (ja) 2009-05-15 2015-10-21 アイ アール エックス セーラピューティクス， インコーポレイテッド ワクチン免疫療法
CN103097543A (zh) 2009-12-08 2013-05-08 伊尔克斯治疗有限公司 逆转朗格汉斯细胞免疫抑制的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570911B2 (en) * 1981-11-06 1988-03-31 Baylor College Of Medicine Immunoadsorbent based on immobilized protein a and its use
CA1204667A (en) * 1982-10-04 1986-05-20 Masashi Kodama Blood treating material
JPS60501558A (ja) * 1983-06-13 1985-09-19 マリエッテ、コンサルタンツ、リミテッド インタ−フエロン感受性疾病の治療方法およびγ−インタ−フエロン含有製剤の製造方法および装置
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
EP0147689B1 (en) * 1983-12-05 1990-09-19 Asahi Kasei Kogyo Kabushiki Kaisha A method of inducing antitumor immunocytes, and a process for producing antitumor immunocytes and antitumor immunocytes produced by the process
DE68909254T2 (de) * 1988-01-25 1994-04-28 American Cyanamid Co Heparinbindende Gehirnmitogene.
WO1989007448A1 (en) * 1988-02-12 1989-08-24 Regents Of The University Of California Use of synthetic peptides to generate and manipulate cellular immunity

Also Published As

Publication number Publication date
EP0406317A1 (en) 1991-01-09
JPH03503640A (ja) 1991-08-15
WO1989009619A1 (en) 1989-10-19
KR900700131A (ko) 1990-08-11
AU632999B2 (en) 1993-01-21
AU3420689A (en) 1989-11-03

Similar Documents

Publication Publication Date Title
Metcalf et al. Formation of eosinophilic‐like granulocytic colonies by mouse bone marrow cells in vitro
US4444887A (en) Process for making human antibody producing B-lymphocytes
RAPOPORT Dog thyroid cells in monolayer tissue culture: adenosine 3', 5'-cyclic monophosphate response to thyrotropic hormone
Zanetta et al. The presence of 2′, 3′‐cyclic AMP 3′‐phosphohydrolase in glial cells in tissue culture
Sugiura et al. Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity.
Okada et al. The differentiation of cytotoxic T cells in vitro: I. Amplifying factor (s) in the primary response is Lyt 1+ cell dependent
AU9058091A (en) Preparation of nucleic acid samples
CA2259984A1 (en) Precise efficacy assay methods for active agents including chemotherapeutic agents
WO1996023060B1 (en) Method for isolating dendritic cells
Stasny et al. The effect of sonic oscillation on the structure and function of beef heart mitochondria
Vallee et al. Purification of microtubules and microtubule-associated proteins from sea urchin eggs and cultured mammalian cells using taxol, and use of exogenous taxol-stabilized brain microtubules for purifying microtubule-associated proteins
ES2132063T3 (es) Procedimiento para la captura y recuperacion de celulas.
SE8801426D0 (sv) Forfarande och medel for blodbehandling
HUP0302796A2 (hu) Eljárás humán szövetből nyert rákos sejtek szaporítására és berendezés a szövetminták feldolgozására
Kahan Isolation of a soluble transplantation antigen
Pope et al. Two distinct populations of suppressor cells in the spleens of mice bearing methylcholanthrene-induced tumors
EP0049611B1 (en) A t-cell growth factor, and a process of producing the same
Basch et al. Thymopoietin-induced acquisition of responsiveness to T cell mitogens
Altman et al. Natural cell-mediated cytotoxicity in guinea pigs: properties and specificity of natural killer cells
Askanas et al. Histochemistry of cultured aneural chick muscle. Morphological maturation without differentiation of fiber types
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
ATE76751T1 (de) Verfahren zur isolierung des blutgerinnungsfaktors ix.
Moskalewski et al. Presence of egg antigen in immature oocytes and preimplantation embryos
NO912621L (no) Fremgangsmaate for innfoering av dna i animalske celler.
Tsang et al. Modulation of T-and B-lymphocyte functions by isoprinosine in homosexual subjects with prodromata and in patients with acquired immune deficiency syndrome (AIDS)